Skip to main content
. 2020 Aug 20;64(9):e00890-20. doi: 10.1128/AAC.00890-20

TABLE 2.

Daptomycin susceptibility and mprF polymorphisms with β-lactam passage after 28 daysa

Isolate Passage Replicate DAP MIC (mg/liter) β-lactam MIC (mg/liter)b mprF SNP MprF domain div1b mutation rpoB/C mutation
J01 None 0.5
J03 None 2 T345I Bifunctional rpoB S464P
Media i 2 None
Mediaa ii 1 Y325H Bifunctional
Mediaa iii 1 R437P Synthase
CROc ii 0.75 512 V152G Translocase
LOXc ii 0.125 32 R788L Synthase Q425d
LOXc iii 0.125 32 R788L Synthase Q415d
D592 None 0.5
D712 None 2 L341S Bifunctional
Media i 2 None
Media ii 1 None
Media iii 2 None
NAFe iii 1 256 S337P Bifunctional
CROe i 2 2,048 M609T Synthase rpoC A567V
CROe iii 0.5 2,048 G389A Synthase rpoB G767C
FOXe ii 0.5 512 F657L Synthase
LOXe i 0.5 1,024 S136L Translocase
LOXe ii 0.5 1,024 S136L Translocase
C24 None 0.5 - -
C25 None 3–4 S295L Bifunctional
Mediaf i 1 S825d Synthase
Mediaf ii 1 S825d Synthase
Media iii 2 None -
FOXf Iii 1 64 A315S Bifunctional
LOXf i 0.125 8 L84d Translocase A420E
LOXf ii 0.125 8 L84d Translocase
LOXf iii 0.125 8 L84d Translocase E416d
a

For the β-lactam-exposed strains, only the passages with additional mprF mutations (versus DAP-NS parent strain) are presented.

b

β-lactam MIC represents the MIC in the respective β-lactam after passage.

c

Passage isolates maintained MprF T345I and RpoB S464P.

d

Nonsense stop-gain mutation resulting in premature end of translation.

e

Passage isolates maintained MprF L341S.

f

Passage isolates maintained MprF S295L.